Literature DB >> 6378378

UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma.

H B Grossman, G Wedemeyer, L Ren, T E Carey.   

Abstract

A permanent cell line (UM-SCP-1) has been established from a primary squamous cell carcinoma of the prostate. UM-SCP-1 has been passaged 40 times and has been in culture for 22 months. The doubling time of this aneuploid cell line is approximately 36 hr. In nude mice, UM-SCP-1 produces rapidly growing tumors with distinct histological features of squamous cell carcinoma. UM-SCP-1 cells express pemphigus and pemphigoid antigens and bind antibodies to beta 2 microglobulin and HLA-A,B,C common antigen. Cells of this line are unreactive with anti-A and anti-B blood group typing sera, autologous serum, and monoclonal anti-HLA-DR antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378378

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation.

Authors:  M J Worsham; S R Wolman; T E Carey; R J Zarbo; M S Benninger; D L Van Dyke
Journal:  Mol Pathol       Date:  1999-02

2.  Autologous antibodies to human bladder cancer.

Authors:  H B Grossman; G Wedemeyer; J Stein
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Establishing prostate cancer patient derived xenografts: lessons learned from older studies.

Authors:  Pamela J Russell; Peter Russell; Christina Rudduck; Brian W C Tse; Elizabeth D Williams; Derek Raghavan
Journal:  Prostate       Date:  2015-01-05       Impact factor: 4.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.